Prognostic biomarker TPM4 acts as a potential predictor of PD-1/PD-L1 inhibitor response in glioblastoma

Asian J Surg. 2024 Apr 22:S1015-9584(24)00704-8. doi: 10.1016/j.asjsur.2024.04.044. Online ahead of print.
No abstract available

Keywords: Biomarker; Glioblastoma; Immunotherapy; TPM4.

Publication types

  • Letter